Abstract

The HRAS promoter contains immediately upstream of the transcription start site two neighboring G-elements, each capable of folding into a G-quadruplex structure. We have previously found that these G-quadruplexes bind to the zinc-finger transcription factors MAZ and Sp1. In the present study we have examined the interaction between the HRAS promoter and MAZ, demonstrating for the first time that the protein unfolds the G-quadruplex structures. We also demonstrate that MAZ-GST, in the presence of the complementary strands, promotes a rapid transformation of the two HRAS quadruplexes into duplexes. By a mutational analysis of the HRAS G-elements, we dissected the MAZ-binding sites from the quadruplex-forming motifs, finding that the two neighboring G-quadruplexes bring about a dramatic repression of transcription, in a synergistic manner. We also discovered that the two G-quadruplexes are strong targets for small anticancer molecules. We found that a cell-penetrating anthratiophenedione (ATPD-1), which binds tightly to the G-quadruplexes (ΔT > 15°C), promotes the total extinction of HRAS transcription. In contrast, when one of the two G-quadruplexes was abrogated by point mutations, ATPD-1 repressed transcription by only 50%. Our study provides relevant information for the rationale design of targeted therapy drugs specific for the HRAS oncogene.

Highlights

  • The ras genes encode for GTP-binding proteins of 21 kDa (p21RAS) sharing a high degree of homology [1]

  • It can be seen that 0.5 ␮g of MAZ-glutathione S-tranferase (GST) is sufficient to detect its binding to duplex hras-2, while the binding to duplex hras-1 is observed at 2 ␮g protein

  • For the first time we demonstrate by fluorescence-resonance energy transfer (FRET) experiments that recombinant MAZ unfolds the HRAS G-quadruplexes

Read more

Summary

Introduction

The ras genes encode for GTP-binding proteins of 21 kDa (p21RAS) sharing a high degree of homology [1]. The therapeutic strategies proposed to cure bladder cancer or to sensitize bladder cancer cells to conventional chemotherapy are based on the use of farnesyltransferase inhibitors. These compounds are able to block the binding of the ras protein to the cell membrane or inhibit the downstream RAS/MEK/ERK pathway, which stimulates cell growth in urinary cancer cells [8]. Todd and Neidle [10] first discovered a correlation between quadruplex-forming sequences in the immediate upstream region of certain human genes and the occurrence of zinc-finger binding motifs (Sp1). The function of MAZ in gene promoters is rather complex, as it can both activate [13,14] or inhibit [15,16,17] gene expression

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call